Related Experiment Video
Updated: Jun 24, 2026
06:15
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Consensus on Neonatal and Pediatric Interfacility Transport
Corina Noje1, Ranna Rozenfeld2, Robert G Holcomb3
1Johns Hopkins University School of Medicine, Baltimore, MD.
Air Medical Journal
|June 22, 2026
Summary
Neonatal and pediatric transport medicine has advanced significantly. This review details current expert consensus on best practices and future directions for interfacility transport teams.
Area of Science:
- Pediatric critical care
- Transport medicine
- Emergency medicine
Background:
- Neonatal and pediatric transport medicine has evolved beyond basic critical care.
- Teams now engage in research, quality improvement, and innovative care delivery.
- The last consensus document is over 10 years old, necessitating an update.
Purpose of the Study:
- To present current evidence-based expert consensus on neonatal and pediatric transport medicine.
- To outline recommendations for the future of the field.
- To address advancements in interfacility transport care.
Main Methods:
- Expert consensus review
- Evidence-based practice analysis
- Literature synthesis on transport medicine advancements.
Main Results:
- Significant advancements in neonatal and pediatric transport medicine practices.
- Established collaborative research, quality improvement, and innovative partnerships.
- Identified areas for future development and dissemination of new practices.
Conclusions:
- The field of neonatal and pediatric transport medicine requires updated consensus guidelines.
- Dissemination of new practices is crucial for advancing patient care.
- Future directions emphasize continued innovation and collaboration in interfacility transport.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:19Standards of Care II
Nurses bear specific legal responsibilities under several federal statutes, including:
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...